Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00473707
Status:
COMPLETED
Last Update Posted:
2023-04-12
First Post:
2007-05-14
Brief Title:
Active Versus Expectant Management of the Third Stage of Labor
Sponsor:
Christiana Care Health Services
Organization:
Christiana Care Health Services
Study Overview
Official Title:
A Randomized Trial of Active Versus Expectant Management of the Third Stage of Labor
Status:
COMPLETED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if giving oxytocin immediately after delivery causes less bleeding transfusion needs and hastens delivery of placenta
Detailed Description:
Postpartum hemorrhage is the leading cause of maternal mortality worldwide During the third stage of labor the period following the delivery of the baby until the delivery of the placenta the patient is at increased risk for blood loss Controversy remains as to the optimal method of delivering the placenta Two predominant yet very different strategies have emerged Expectant management is most commonly used in the United States This includes waiting for signs of placental separation followed by maternal pushing to expel the placenta Then uterotonic agents are administeredusually oxytocin This is in contrast to active management which consists of uterotonic administration immediately following delivery of the fetus in association with gentle umbilical cord traction and fundal massage This is the predominant practice in the United Kingdom where the uterotonic agents of choice are either oxytocin alone or a combination of oxytocin and ergometrine
Comparison Active management with oxytocin to expectant management of the third stage of labor on the effect of postpartum hemorrhage
Comparison Active management with oxytocin to expectant management of the third stage of labor on the effect of postpartum hemorrhage
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None